CAAR-T
Dr. Aimee Payne’s Path to Creating CAAR-T Cell Therapies
In 2011, Aimee Payne, MD, PhD, was running a lab at the University of Pennsylvania, studying pemphigus vulgaris, an autoimmune disease of the skin that results when B cells make antibodies that attack the cell-adhesion protein desmoglein 3.